ATP7A and breast carcinoma: In summary, the present study identified copper efflux transporter ATP7A, as a novel target of miR‐148a‐3p, played a critical role in resistance of breast cancer cells to cisplatin via sequestering and pumping cisplatin out of cancer cells.